March 03, 2026

Ivermectin vs Permethrin for Scabies

Investigators evaluate household-level cure rates in dermoscopy-confirmed cases at day 28.

Conexiant

February 27, 2026

Unexpected Diagnosis in Ring Finger Mass

Histopathology reveals digital actinomycosis in a young patient.

Conexiant

February 20, 2026

Allergen Sensitization in Skin of Color

Scoping review links contact allergy to AD severity

Conexiant

February 19, 2026

Afro-Textured Hair: Clinical Framework for Care

Investigators examine clinician communication, updated hair classification, and culturally informed care in Afro-textured hair.

Conexiant

February 18, 2026

Combo Therapy for Psoriasis With Obesity

A phase 3b trial tests ixekizumab plus tirzepatide in adults with moderate-to-severe plaque psoriasis and obesity or overweight.

Conexiant

February 13, 2026

Primary Care’s Rug Pulled Out?

CMS abruptly scraps a 10-year primary care model, leaving nearly 700 practices rethinking staffing, funding, and patient access.

KFF Health News

February 12, 2026

Curbing Drug-Related Halitosis for Closer Moments

Individuals who have drug-related halitosis may need to take additional steps to prioritize oral health before intimate encounters.

Conexiant

February 10, 2026

When Obesity Meets Infection Risk

Researchers analyze data from Finnish cohorts and the UK Biobank to examine how body mass index relates to severe infections and their global burden.

Conexiant

February 09, 2026

Dupilumab and Lymphoma Risk in AD?

Dupilumab is safe from a lymphoma-risk perspective in atopic dermatitis and other type 2 inflammatory diseases, based on real-world data.

Conexiant